Stock GMAB N GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Genmab A/S Mexican S.E.

Equities

GMAB N

DK0010272202

End-of-day quote Mexican S.E.
Other stock markets
 07:00:00 2024-03-26 pm EDT 		5-day change 1st Jan Change
5,100 MXN +3.92% Intraday chart for Genmab A/S -.--% -4.52%
Jun. 04 Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating MT
Jun. 03 Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study MT

Chart calendar Genmab A/S

f3746e6b262b08cb962deccdb43.mhoTucmasV0sp19skh28IClfqVzlT0XHkN0sla_SCOc.80VE4bjW0igb4S8W2m2RZ2w00wOueQa90YpO4vmaUpOsYGaMneDeKhXVBg~4823cc417d3a978a3ac8d1000921f137

Upcoming events on Genmab A/S

2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2059
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2081
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :PB2955
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2060
2024-06-14 08:45 am European Hematology Association Meeting - Abstract Number :S239
2024-06-14 08:45 am European Hematology Association Meeting - Abstract Number :S163
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1244
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1133
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1140
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1121
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1114
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1161
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1152
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1151
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1146

Past events on Genmab A/S

2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS7084
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7039
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7037
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7032
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7029
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:5531
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract No:6012
2024-06-02 05:30 pm American Society of Clinical Oncology Meeting - Abstract No:7015
2024-06-02 05:30 pm American Society of Clinical Oncology Meeting - Abstract No:7014
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract No:2533
2024-05-02 12:00 pm Q1 2024 Earnings Call
2024-05-02 11:01 am Q1 2024 Earnings Release
2024-04-03 07:00 am Acquisition of ProfoundBio by Genmab A/S Call
2024-03-13 09:00 am Annual General Meeting
2024-03-05 TD Cowen Health Care Conference
2024-02-27 UBS European Healthcare Conference
2024-02-14 12:00 pm Q4 2023 Earnings Call
2024-02-14 11:02 am Q4 2023 Earnings Release
2024-01-10 02:15 pm JPMorgan Healthcare Conference
2023-12-12 11:00 am R&D Day

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK		Released
Forecast
Spread 		5 366
5 159
4.02%		10 111
9 843
2.72%		8 482
8 376
1.26%		14 595
14 068
3.75%		16 474
16 380
0.58%
19 796

EBITDA
Million DKK		Released
Forecast
Spread 		2 777
2 460
12.89%		6 572
6 099
7.75%		3 266
3 111
4.98%		6 719
6 371
5.46%		5 616
5 721
-1.83%
6 346

EBIT
Million DKK		Released
Forecast
Spread 		2 638
2 317
13.83%		6 313
5 967
5.79%		3 018
2 960
1.96%		6 357
6 008
5.81%		5 321
5 398
-1.42%
5 359

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		2 859
2 645
8.11%		5 904
5 723
3.17%		3 983
3 731
6.77%		7 035
8 905
-21%		5 637
6 236
-9.6%
5 874

Net income
Million DKK		Released
Forecast
Spread 		2 166
2 085
3.89%		4 758
4 706
1.1%		3 008
2 847
5.64%		5 522
6 793
-18.71%		4 352
4 989
-12.77%
4 680

EPS
DKK		Released
Forecast
Spread 		34,0
32,8
3.61%		72,2
69,4
4.06%		45,5
43,8
3.94%		83,7
104
-19.22%		66,0
76,2
-13.35%
68,1

Announcement Date19/02/2023/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales
Million DKK		Released
Forecast
Spread 		6 343
6 164
2.9%		3 553
3 224
10.2%		2 619
2 538
3.19%		2 119
2 074
2.15%		3 162
2 833
11.6%		5 281
5 136
2.82%		4 087
3 634
12.46%		5 227
4 727
10.57%		2 854
2 809
1.62%		4 198
4 070
3.13%		7 052
6 896
2.26%		4 744
4 474
6.03%		4 678
4 610
1.48%		4 143
3 974
4.25%
4 991


9 039


5 284


5 582


5 229

EBITDA
Million DKK		Released
Forecast
Spread 		4 583
4 480
2.3%		1 345
980
37.24%		1 016
776
30.87%		529
358
47.73%		1 263
1 312
-3.74%		1 792
1 951
-8.15%		1 953
1 583
23.36%		2 974
2 708
9.84%		458
583
-21.48%		1 520
1 670
-8.96%		1 978
2 145
-7.79%		1 739
1 646
5.65%		1 899
1 804
5.28%		823
834
-1.33%
1 511


2 412


1 711


2 070


2 850

EBIT
Million DKK		Released
Forecast
Spread 		4 568
4 389
4.08%		1 319
864
52.66%		809
772
4.76%		514
442
16.3%		1 247
1 156
7.87%		1 761
1 814
-2.92%		1 931
1 541
25.34%		2 665
2 314
15.17%		437
527
-17.08%		1 497
1 573
-4.85%		1 934
1 977
-2.18%		1 717
1 702
0.87%		1 670
1 772
-5.73%		801
765
4.72%
391


2 229


1 631


1 827


1 547

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		4 682
4 682
0%		1 846
1 759
4.95%		966
772
25.06%		612
499
22.59%		2 489
1 183
110.39%		3 101
1 932
60.51%		3 272
1 584
106.63%		662
2 199
-69.9%		286
402
-28.85%		1 723
1 602
7.57%		2 009
1 927
4.26%		2 702
1 774
52.33%		926
1 888
-50.95%		1 716
744
130.64%
185


3 374


1 698


1 733


1 634

Net income
Million DKK		Released
Forecast
Spread 		3 647
4 573
-20.25%		1 402
1 372
2.19%		716
603
18.69%		465
357
30.19%		1 891
913
107.1%		2 356
1 469
60.38%		2 582
1 187
117.46%		584
1 556
-62.47%		226
397
-43.08%		1 357
1 204
12.72%		1 583
1 503
5.32%		2 129
1 382
54.01%		640
1 439
-55.52%		1 325
736
79.97%
456


2 598


1 363


1 355


1 280

EPS
DKK		Released
Forecast
Spread 		55,5
70,2
-20.91%		21,3
20,9
1.67%		10,8
9,25
16.99%		7,05
5,39
30.88%		28,7
13,8
106.99%		35,7
22,1
61.58%		39,2
18,3
113.88%		8,82
23,2
-61.91%		3,43
5,07
-32.28%		20,6
19,3
7.03%		24,0
22,7
5.86%		32,3
21,2
52.42%		9,67
23,0
-57.93%		20,2
8,93
126.09%
-2,25


39,5


19,3


19,1


14,9

Announcement Date12/08/2011/08/2116/02/2211/05/2210/08/2210/08/2209/11/2222/02/2310/05/2303/08/2303/08/2307/11/2314/02/2402/05/24-----

Upcoming sector events for Genmab A/S

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Genmab A/S

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. GMAB N Stock
  5. Calendar Genmab A/S